Home › Funds › Handelsbanken Fonder AB › GILD

Handelsbanken Fonder AB position in GILD

GILEAD SCIENCES INC · Health Care

Handelsbanken Fonder AB reported holding 1,002,847 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$149.5M, representing 0.42% of its reported portfolio and ranking #36 among its reported holdings. Handelsbanken Fonder AB has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.00M sh
Reported value held$149.47M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Handelsbanken Fonder AB's GILD position evolved

Handelsbanken Fonder AB first disclosed a stake in GILD in Q3 2023 at 561,791 shares (US$42.1M). The position peaked in Q3 2026 at 1,002,847 shares, worth US$149.5M. Across 13 filings, Handelsbanken Fonder AB increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,002,847 shares valued at US$149.5M — an increase of 27,758 shares quarter over quarter.. Notable position changes include a 86% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 561.79K $42.10M New
Q4 2023 572.19K $46.35M Add
Q1 2024 498.96K $36.55M Reduce
Q2 2024 549.42K $37.70M Add
Q3 2024 538.70K $45.16M Reduce
Q4 2024 590.16K $54.51M Add
Q1 2025 1.09M $122.68M Add
Q2 2025 1.16M $129.09M Add
Q3 2025 1.15M $127.80M Reduce
Q4 2025 1.07M $131.29M Reduce
Q1 2026 1.05M $146.50M Reduce
Q2 2026 975.09K $123.19M Reduce
Q3 2026 1.00M $149.47M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Handelsbanken Fonder AB held GILD?

Handelsbanken Fonder AB has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Handelsbanken Fonder AB's current position in GILD?

As of Q3 2026, Handelsbanken Fonder AB holds 1.00M shares of GILD (GILEAD SCIENCES INC), valued at $149.47M, representing 0.42% of its reported portfolio and ranking #36.

Has Handelsbanken Fonder AB been buying or selling GILD?

In the latest 13F filing (Q3 2026), Handelsbanken Fonder AB increased its position in GILD. The position peaked in Q3 2026 at 1.00M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.